|1.||Srinivasan, Krishnapura: 3 articles (09/2014 - 04/2012)|
|2.||Suresha, Bharathinagar S: 3 articles (09/2014 - 04/2012)|
|3.||Sattur, Avinash P: 1 article (04/2012)|
|1.||Diabetic Nephropathies (Diabetic Nephropathy)
09/01/2014 - "Fungal metabolite nigerloxin ameliorates diabetic nephropathy and gentamicin-induced renal oxidative stress in experimental rats."
09/01/2014 - "Thus, the results indicated the beneficial influence of nigerloxin on polyol pathway and oxidative stress associated with diabetes, which are implicated in ameliorating the development of diabetic nephropathy. "
10/01/2013 - "In the present study, the beneficial influence of nigerloxin was investigated in galactose-induced cataract in experimental animals. "
10/01/2013 - "The results suggest that alteration in polyol pathway and antioxidant defense system were countered by nigerloxin in the lens of galactose-fed animals, suggesting the potential of nigerloxin in ameliorating the development of galactose-induced cataract in experimental animals."
04/01/2012 - "The results suggest the beneficial countering of polyol pathway enzymes and potentiation of the antioxidant defense system by nigerloxin in diabetic animals, implicating its potential in ameliorating cataracts in diabetics."
|3.||Body Weight (Weight, Body)
09/01/2014 - "Groups of rats were orally administered with nigerloxin for 8 days (25 mg or 100 mg kg(-1) body weight day(-1)) along with gentamicin (80 mg/kg, i.p., for 8 days). "
10/01/2013 - "Groups of galactose-fed rats were orally administered with nigerloxin (25 and 100 mg/kg body weight/day) for 24 days. "
10/01/2013 - "Oral administration of nigerloxin once a day for 24 days at a dose of 100 mg/kg body weight, significantly decreased lens lipid peroxides and advanced glycation end products in galactose-fed rats. "
|4.||Advanced Glycosylation End Products